Ardent Health, Inc. Proceeds from Lines of Credit
Ardent Health, Inc. (ARDT) reported Proceeds from Lines of Credit of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-03-16
- Ardent Health, Inc. proceeds from lines of credit for fiscal 2025 was $0.00.
- Ardent Health, Inc. proceeds from lines of credit for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Ardent Health, Inc. proceeds from lines of credit for fiscal 2023 was $125.00M.
- Ardent Health, Inc. proceeds from lines of credit for fiscal 2022 was $0.00.
| Period end | Proceeds from Lines of Credit 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-16 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-16 |
| 2023-12-31 | $125.00M 10-K · filed 2026-03-16 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |